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Abstract 
    Type II Diabetes Mellitus (T2DM) is a high-risk metabolic condition associated with high mortality due to 
hyperglycemia. Many studies have focused on how inflammation, aging, or oxidative stress influences the 
pathogenesis of T2DM. The functional anomalies of the pancreatic beta cells attribute to insulin resistance which 
is the primary cause of T2DM manifestations and complications. This is evidenced in polymorphism in the TNF-α 
gene which inhibits insulin production, metabolism, and utilization during T2DM development. The dysregulation 
of insulin signaling involves multiple pathways. Various factors such as epigenetics, oxygen radicals, and 
glucolipotoxicity are implicated in the pathogenesis. Low-grade inflammation mediated by pro-inflammatory 
cytokines and chemokines such as interleukin-1 attack peripheral tissues and mediates the activation of critical 
pathways involved in T2DM pathogenesis via transcriptional factors. The core factor resulting in inflammation is 
hyperglycemia. The result is the release of inflammatory mediators which then affect neurons in the nervous 
system and alter microvascular and enzymatic pathways to elicit severe complications such as neuropathy. 
Oxidative stress and inflammation share an intertwined relationship in the pathogenesis of T2DM. High levels of 
reactive oxygen species increase the level of DNA damage markers and expose pancreatic beta-cell lines to 
dysregulation through reduced expression of the insulin gene. The link between the interaction of oxidative stress 
and inflation in the human body increases the level of interleukin-6 which triggers superoxide radicles and 
oxidative stressors increase which have been shown to affect free fatty acids metabolism inversely Finally, the 
aspect of cellular senescence in adipocytes and pancreatic beta cells explain why age is a critical factor in T2DM 
pathogenesis. Overall, the three factors discussed have a crucial role in T2DM disease states, progressions, and 
complications. 
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Introduction 
    The multifactorial, evolving, and complex nature of 
type II diabetes mellitus (T2DM) makes it a significant 
risk factor for mortality due to hyperglycemia [1,2]. 
The review [3] presents an in-depth discussion on how 
inflammation, aging, and oxidative stress exacerbate 
the pathophysiology of T2DM and its direct and 
indirect complications on the vascular tree. The 
commentary offers a more profound insight into how 
the three factors interact with T2DM and complement 
the knowledge presented in the review. 
 
The Pathogenesis of T2DM 
    The review article presents pancreatic beta cells 
dysfunction as the mainstay of T2DM pathophysiology 
as a result of peripheral resistance and insensitivity to 
insulin and dysregulation of hepatic glucose 
production. Various characteristics of T2DM 
pathogenesis can support the rate at which the 
associated complications occur. As [4–6] discussed the 
activation of multiple pathways mediated by 
transcriptional factors with the augmentation of 
varying levels of pro-inflammatory cytokines results in 
the manifestation of the primary characteristic in 
T2DM: insulin resistance. Also, [4,7] outlines that 
epigenetic factors, reactive oxygen species (ROS) 
generation, and glucolipotoxicity are the multi-stimuli 
factors that play a critical role in T2DM pathogenesis. 
All the above would explain why [3] discussed the 
events that result in defects in the homeostatic 
processes of glucose metabolism. 
 
Inflammation and T2DM 
    Many pro-inflammatory cytokines play a critical 
role in the development and progression of T2DM and 
its complications through low-grade inflammation 
(recently defined as “metaflammation”) [8,9]. The 
tumour necrosis factor-alpha (TNF- α) stands out as 
the most crucial pro-inflammatory mediator with 
critical involvement in insulin resistance and T2DM 
pathogenesis [4]. Considering that the peripheral 
tissues and adipocytes are the primary producers of 
TNF- α (and other cytokines such as interleukin-1 and 
6) [10–12] would explain why [3] discuss obesity when 
linking inflammation to T2DM. Also, the pro-
inflammatory mediator has a significant role in the 
induction of tissue-specific inflammation because it 
incorporates the ROS generated as well as activate 
pathways mediated by transcriptional factors involved 
in T2DM pathogenesis [13,14]. The review highlighted 
that inflammatory responses could either augment or 
establish a causal relationship to T2DM which implies 
that high levels of inflammatory mediators can induce 
insulin resistance in peripheral and adipose tissues by 
impairing pathways of insulin signaling.  
 
    High glucose concentration results in the release of 
inflammatory mediators. The hyperglycemia-induced 
production of pro-inflammatory cytokines affects 
neurons in the autonomic, central, and peripheral 
nervous systems. These effects result in enzymatic, 
metabolic, and microvascular alterations, which would 
explain why T2DM patients present with diabetic 
neuropathy as the primary complication of the disease 
[2,9,15,16]. Overall, the pancreatic cells, adipose 
tissues, and muscle cells are crucial sites of pro-
inflammatory cytokines production in the presence of 
obesity. The cells act as paracrine and autocrine 
pathways that enhance resistance to insulin by 
disrupting its signaling in peripheral tissues. 
 
    Increased level of cytokines has been shown to pose 
a risk in T2DM development and progression. 
Research has found that TNF- α -863C>A, IL-6-
174C>G is associated with the cause of diabetes 
mellitus by approximate two-fold [18].  This due to the 
ability of the genes to promote polymorphism in the 
TNF-α gene, which is a predictor in the conversion of 
IGT to T2DM as well as gene-gene interaction in C-
174C genotype of the IL-6 gene. In a different case, the 
IL6 in adipose and hepatic tissues presents pro-
inflammatory adipokine thus cause insulin resistance. 
Through increased insulin resistance, the adipokine 
impairs its receptors and IRSI phosphorylation, thus 
increasing the prevalence of T2DM development. 
Increased resistance to insulin utilization during 
glucose metabolism results in the continuous 
accumulation of fatty acids in the body, thus increasing 
the prevalence of obesity (Table-1).  
 
Oxidative Stress and T2DM 
    Inflammation    and    oxidative    stress    have     an 
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inextricable relationship in the physiological and 
disease states and this would explain why the 
reviewers provide a more comprehensive discussion 
on ROS and inflammation as well as ROS and oxidative 
stress. Both aspects have a complex interaction in 
which there is mutual amplification, which can be 
termed as a “vicious cycle” or a positive feedback 
mechanism [4,19,20]. Although [3] fails to provide an 
explicit link between oxidative stress and T2DM, 
[19,21,22] discuss that a hyperglycaemic state can 
result in elevation of DNA damage markers, and 
products of protein and lipid peroxidation, all of which 
lower enzymatic activity of antioxidants. Also, 
exposure of pancreatic beta-cell lines to oxidative 
stress inhibits insulin gene expression through reduced 
mRNA expression, which yields chronic insulin 
resistance, induced by chronic hyperglycemia 
[16,23,24]. One critical point to consider when 
establishing a link between oxidative stress and T2DM 
pathogenesis is that prolonged exposure of cells to 
hyperglycaemic results in non-enzymatic protein 
glycation which yields products that culminate ROS 
production [21,25]. As such, chronic hyperglycemia 
induces ROS production which damages proteins, 
lipids, and DNA, promoting macro-and microvascular 
complications of T2DM [20,26-28]. As [3] attempt to 
link oxidative stress and ROS, it is apparent that the 
former reduces the production of glutathione (GSH) 
which consequently exacerbate the latter. 
 
    The pathophysiology of T2DM indicates that 
oxidative stress plays a critical role in insulin 
resistance pathogenesis. This is characterized by 
impaired insulin secretion and inhibited glucose 
utilization which results in impaired hepatic glucose 
metabolism alongside pro-inflammation cytokines 
inflammation activation. Chronic progression of T2DM 
is, therefore believed to be linked to the interaction of 
oxidative stress and inflation in the human body. The 
increase in the level of interleukin-6 directly increases 
superoxide radicles and oxidative stressors which  
have been shown to affect free fatty  acids  metabolism  
 
 
 
 
 
 
 
 
 
 
 
Table-1: Some pro-inflammatory cytokines single nucleotide polymorphism (SNPs) that are closely 
related to T2DM pathogenesis [17] 
Condition SNP 
T2DM TNF- α -863C>A, IL-6-174C>G 
Insulin resistance TNF- α -308G>A, IL-5-174C>G 
Obesity TNF- α -308G>A, IL6R 394T>G 
 
                   
Fig-1: Relationship between T2DM, Inflammation, and Oxidative Stress [19] 
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inversely. Oxidative stress results in mitochondria 
uncoupling which triggers an oxidative reaction, thus 
eliciting the inflammatory process [19] (Fig-1). 
 
Aging and T2DM 
    There is a close association between aging and 
insulin resistance as a result of reduced beta-cell 
proliferation and increased sensitivity to apoptosis 
[3,28,29] which implies that older adult populations 
are more susceptible to insulin insensitivity. The 
apparent reason for the above is because cellular 
senescence emerges as an important mechanism in the 
progression of T2DM among geriatric patients and has 
further implications for conditions such as 
cardiovascular and kidney disease [30]. Obesity is a 
crucial determinant to cellular senescence, particularly 
the pancreatic beta cells and adipocytes, and the 
consequent effects to T2DM disease processes [14,31]. 
Here, aging predisposes a person to adipose tissue 
dysfunction and results in systemic effects such as 
inflammation, ectopic lipid deposition, and peripheral 
insulin resistance, which play a critical role in the 
pathogenesis of T2DM [32]. Also, beta-cell failure due 
to aging has been linked to T2DM pathophysiology due 
to monogenic dysfunction of mitochondria where 
apoptotic pathways converge [33]. The reviewers 
presented a general overview of the phenomena 
discussed, linked it the explanation to oxidative stress 
using sarcopenia as the primary concept. All the above 
demonstrate that age is an inevitable risk factor to 
T2DM. 
 
Conclusion  
    The reviewers provided a comprehensive overview 
of how aging, inflammation, and oxidative stress affect 
the pathogenesis of T2DM. The utilization of insulin in 
the control of the human body glycaemic index is 
controlled by TNF- α genes which activate pro-
inflammation cytokines inflammation, superoxide 
radicles and oxidative stressors increase. The 
prevailing view in the discussion presented in this 
commentary is that all three factors have a critical role 
in inhibiting insulin production pathways and the 
resulting resistance to insulin. Moreover, there is an 
intertwined relationship between the three factors in 
exacerbating T2DM progression among individuals 
and can guide the development of targeted therapies. 
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